J. Michael Jones Fresenius Medical Care (NYSE:FMS) appointed Helen Giza as CEO, with immediate effect, about a month after the company cut its 2022 outlook and it was reported that activist investor Elliott Investment Management had a 3% stake in the company. Giza, who previously served as deputy CEO and […]